Coagulation factors XI and XII as possible targets for anticoagulant therapy
- 25 April 2022
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 214, 53-62
Abstract
No abstract availableKeywords
This publication has 110 references indexed in Scilit:
- Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or DabigatranStroke, 2012
- Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in MiceTranslational Stroke Research, 2012
- Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeysBlood, 2012
- A role for factor XIIa–mediated factor XI activation in thrombus formation in vivoBlood, 2010
- Novel Hemostatic Factor Levels and Risk of Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) StudyCerebrovascular Diseases, 2010
- COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, does not protect mice from acute ischemic strokeExperimental & Translational Stroke Medicine, 2010
- Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In VivoCell, 2009
- Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism EtiologyBlood, 2009
- Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XIBlood, 2009
- Triggers, targets and treatments for thrombosisNature, 2008